Article
Geographic variation in dementia-related adverse events associated with sacubitril/valsartan: Analysis of the FDA Adverse Event Reporting System
2023-10-31
Abstract excerpt
<title>Abstract</title> <p>This study aimed to investigate geographical variation in the risk of dementia-related adverse events (AEs) associated with sacubitril/valsartan. Cases from the FDA Adverse Event Reporting System involving patients aged 60 or older with sacubitril/valsartan or angiotensin receptor blockers (ARBs) were analyzed. The reporting odds ratios (RORs) for dementia-related AEs were calculated fo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d761548f-f0b7-5739-baba-f1f652ed7a50
- DOI
- 10.21203/rs.3.rs-3482453/v1
